Table 5.
CREB Pathway (score = 17.43)—22 genes |
ARHGEF6, AXL, BMP3, CACNA2D3, CACNG6, CLU, EPHA3, EPHB3, FLT1, FLT3, GNA14, GNB5, GNRH1, GRID2, HTR3E, PDE1C, PRKCH, SEMA5A, SLC8A2, TEK, THPO, VAV3 |
Actin Nucleation by ARP-WASP Complex (score = 14.94)—16 genes |
ARHGEF6, AXL, EPHA3, EPHB3, FLT1, FLT3, GNA14, GNB5, ITGAE, ITGB6, LPAR1, LPAR3, MYH1, MYH7, MYO7A, TEK |
Akt Signaling (score = 14.53)—24 genes |
AXL, BMP15, BMP3, CCL17, CD28, CD80, EPHA3, EPHB3, FCER1G, FLT1, FLT3, GNA14, GNB5, GNRH1, IL10, ITGAE, ITGB6, PRKCH, PXDN, SEMA5A, TEK, THPO, TNFSF8, VAV3 |
ERK Signaling (score = 14.11)—34 genes |
ARHGEF6, AXL, BMP15, BMP3, CACNA2D3, CACNG6, CCL17, CD28, CD80, CDH13, ECM2, EPHA3, EPHB3, FBN1, FLT1, FLT3, GNA14, GNB5, GNRH1, IL10, ITGAE, ITGB6, LAMA4, MUC1, MYC, MYH1, MYH7, MYO7A, PRKCH, PXDN, SEMA5A, TEK, THPO, TNFSF8 |
TGF-BETA (score = 11.30) 21 genes |
ARHGEF6, AXL, BMP15, BMP3, CCL17, CD80, EPHA3, EPHB3, FLT1, FLT3, GNA14, GNB5, GNRH1, IL10, ITGAE, ITGB6, MYC, PXDN, SEMA5A, TEK, THPO |
Nanog in mammalian ESC pluripotency (score = 9.82)—17 genes |
AQP2, AXL, BMP3, CDH13, EPHA3, EPHB3, FLT1, FLT3, GNB5, GNRH1, LPAR1, LPAR3, PRKCH, SEMA5A, TEK, THPO, WNT8B |
Shown are those SuperPaths that were highly significant (P < 0.001) as well as two selected pathways that were P < 0.05 (TGF-BETA and Nanog in Mammalian ESC pluripotency)